[ET Net News Agency, 5 January 2026] INNOVENT BIO (01801) rose 5.3% to HK$83.
It hits an intra-day high of HK$83.15, breaking above the 20-D SMA of HK$82.805, and an intra-day low of HK$76.8. The total shares traded was 5.37 million, with a value of HK$432.6m. The active buy/sell ratio is 62:38, with net buying turnover of HK$96.23m. HSBC SEC BRO (ASIA) accounts for greatest net responsive buying turnover of HK$16.8m, with volume weighted average price of HK$81.88. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$42.84m, with volume weighted average price of HK$81.015. The stock has risen a combined 8.9% over the past 2 consecutive trading days.
The Hang Seng Index now rose 41 points, or 0.2% to 26,379; the Hang Seng China Enterprises Index now rose 5 points, or less than 0.1% to 9,174.
Basic Information| Nominal | 83.000 | % Chg | +5.33% |
| High | 83.150 | Low | 76.800 |
| Shares Tr | 5.37m | Turnover | 432.6m |
| 10-D SMA | 80.475 | %H.V | 37.925 |
| 20-D SMA | 82.805 | VWAP | 80.614 |
| 50-D SMA | 86.636 | RSI14 | 48.275 |
Status: Breaking above the 20-D SMA, active buy/sell ratio is 62:38, with net buying turnover of HK$96.23m, rising a combined 8.9% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| INNOVENT BIO (01801) | 83.00 | +5.33 |
| CSPC PHARMA (01093) | 8.73 | +2.95 |
| SINO BIOPHARM (01177) | 6.38 | +0.31 |
| HENGRUI PHARMA (01276) | 75.70 | +2.16 |
| WUXI BIO (02269) | 33.16 | +1.91 |
| WUXI APPTEC (02359) | 104.20 | +3.17 |
| ZIJIN MINING (02899) | 36.52 | -1.14 |
| HANSOH PHARMA (03692) | 36.70 | +0.71 |
| BEONE MEDICINES (06160) | 193.10 | +4.66 |
| AKESO (09926) | 116.40 | +2.74 |
(ed)
